Modulation of eicosanoid metabolism in endothelial cells in a xenograft model. Role of cyclooxygenase-2

Journal of Clinical Investigation

Volumn 100, Issue 5, 1997, Pages 1150-1158

  Bustos, Matilde ^a   Coffman, Thomas M ^a   Saadi, Soheyla ^a   Platt, Jeffrey L ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibodies; Complement; Lipid mediators; Thromboxane synthase; Xenograft

Indexed keywords

ANTIBODY; COMPLEMENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ICOSANOID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; MESSENGER RNA; PROSTACYCLIN; PROSTAGLANDIN E2; THROMBOXANE A2; THROMBOXANE SYNTHASE;

ANIMAL CELL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAFT REJECTION; HUMAN; HUMAN TISSUE; ICOSANOID METABOLISM; NONHUMAN; PRIORITY JOURNAL; SWINE; XENOGRAFT;

EID: 0030923457     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119626     Document Type: Article

References (33)

1. Platt, J.L., G.M. Vercellotti, A.P. Dalmusso, A.J. Matas, R.M. Bolman, J.S. Najarian, and F.H. Bach. 1990. Transplantation of discordant xenografts: a review of progress. Immunol. Today. 11:450-456.
2. Parker, W., S. Saadi, S.S. Lin, Z.E. Holzknecht, M. Bustos, and J.L. Platt. 1996. Transplantation of discordant xenografts: a challenge revisited. Immunol. Today. 17:373-378.
3. Leung, D.Y., J.L. Moake, P.L. Havens, M. Kim, and J.S. Pober. 1988. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet. 2:183-186.
4. Lawson, J.H., and J.L. Platt. 1996. Molecular barriers to xenotransplantation. Transplantation (Baltimore). 62:303-310.
5. Leventhal, J.R., A.J. Matas, L.H. Sun, S. Reif, R.M. Bolman III, A.P. Dalmasso, and J.L. Platt. 1993. The immunopathology of cardiac xenograft rejection in the guinea pig to rat model. Transplantation (Baltimore). 56:1-8.
6. Platt, J.L. 1994. A perspective on xenograft rejection and accommodation. Immunol. Rev. 141:127-149.
7. Saadi, S., N.S. Ihrcke, and J.L. Platt. 1996. Pathophysiology of xenograft rejection. In Principles of Immunomodulatory Drug Development in Transplantation and Autoimmunity. R. Lieberman and R. Morris, editors. Raven Press, Ltd., New York. 31-15.
8. Saadi, S., R.A. Holzkhecht, C.P. Patte, D.M. Stern, and J.L. Platt. 1995. Complement-mediated regulation of tissue factor activity in endothelium. J. Exp. Med. 182:1807-1814.
9. Imagawa, D.K., N.E. Osifchin, L.E. Ramm, P.G. Koga, C.H. Hammer, H.S. Shin, and M.M. Mayer. 1986. Release of arachidonic acid and formation of oxygenated derivatives after complement attack on macrophages: role of channel formation. J. Immunol. 136:4637-1643.
10. Needleman, P., S. Moncada, S. Bunting, J.R. Vane, M. Hamberg, and B. Samuelsson. 1976. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature (Lond.). 261:558-560.
11. Smith, W.L., and L.J. Marnett. 1991. Prostaglandin endoperoxide synthase: structure and catalysis. Biochim. Biophys. Acta. 108:1-17.
12. DeWitt, D.L. 1991. Prostaglandin eudoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta. 1083:121-134.
13. Wrenshall, L.E., F.B. Cerra, A. Carlson, F.H. Bach, and J.L. Platt. 1991. Regulation of T lymphocyte responses by heparan sulfate. J. Immunol. 147: 455-459.
14. Wrenshall, L.E., F.B. Cerra, R.K. Singh, and J.L. Platt. 1995. Heparan sulfate initiates signals in murine macrophages leading to divergent biological outcomes. J. Immunol. 154:871-880.
15. Spurney, R.F., and T.M. Coffman. 1995. The role of eicosanoids in transplant rejection. In Inflammation Mediators and Pathways. R.R. Ruffolo and M.A. Hollinger, editors. CRC Press, Inc., Boca Raton, FL. 173-181.
16. Platt, J.L., G.M. Vercellotti, B.J. Lindman, T.R. Oegema, Jr., F.H. Bach, and A.P. Dalmasso. 1990. Release of heparan sulfate from endothelial cells: implications for pathogenesis of hyperacute rejection. J. Exp. Med. 171: 1363-1368.
17. Parker, W., D. Bruno, Z.E. Holzknecht, and J.L. Platt. 1994. Xenoreactive natural antibodies: isolation and initial characterization. J. Immunol. 153: 3791-3803.
18. Saadi, S., and J.L. Platt. 1995. Transient perturbation of endothelial integrity induced by antibodies and complement. J. Exp. Med. 181:21-31.
19. Platt, J.L., B.J. Lindman, R.L. Geller, H.J. Noreen, J.L. Swanson, A.P. Dalmasso, and F.H. Bach. 1991. The role of natural antibodies in the activation of xenogenic endothelial cells. Transplantation (Baltimore). 52:1037-1043.
20. Masferrer, J.L., B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson, and K. Siebert. 1994. Selective inhibition of inducible cyclooxygenase-2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA. 91:3228-3232.
21. Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159.
22. Vane, J.R., E.E. Anggand, and R.M. Botting. 1990. Regulatory functions of the vascular endothelium. N. Engl. J. Med. 323:27-36.
23. Smith, W.L. 1986. Prostaglandin biosynthesis and its compartmentation in vascular smooth muscle and endothelial cells. Annu. Rev. Physiol. 48:251-262.
24. Habib, A., M.E. Martinuzzo, L.O. Carreras, S. Levy-Toledano, and J. Maclouf. 1995. Increased expression of inducible cyclooxygenase-2 in human endothelial cells by antiphospholipid antibodies. Thromb. Haemostasia. 74:770-777.
25. Ramadan, F.M., G.R. Upchurch, B.A. Keagy, and F. Johnson. 1990. Endothelial cell thromboxane production and its inhibition by a calcium channel blocker. Ann. Thorac. Surg. 49:916-919.
26. Carreras, L.O., and J. Maclouf. 1993. The lupus anticoagulant and eicosanoids. Prostaglandins Leukot. Essent. Fatty Acids. 49:483-488.
27. Karim, S., A. Habib, S. Levy-Toledano, and J. Maclouf. 1996. Cyclooxygenase-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J. Biol. Chem. 271: 12042-12048.
28. Ristimaki, A., and L. Viimikka. 1992. Modulation of prostacyclin production by cytokines in vascular endothelial cells. Prostaglandins Leukot. Essent. Fatty Acids. 47:93-99.
29. Ristimaki, A., S. Garfinkel, J. Wessendorf, T. Maciag, and T. Hla. 1994. Induction of cyclooxygenase-2 by interleukin-1α. Evidence for post-transcriptional regulation. J. Biol. Chem. 269:11769-11775.
30. Crowl, R.M., T.J. Stoller, R.R. Conroy, and C.R. Stoner. 1991. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J. Biol. Chem. 266:2647-2651.
31. Oka, S., and H. Anita. 1991. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes. Two distinct pathways of the gene expression. J. Biol. Chem. 266:9956-9960.
32. 2 in human fibroblasts. J. Biol. Chem. 267:23451-23454.
33. 12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell. 83:803-812.